Navidea Biopharmaceuticals, Inc. (NAVB) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Navidea Biopharmaceuticals, Inc. (NAVB) Bundle
Looking to assess the intrinsic value of Navidea Biopharmaceuticals, Inc.? Our (NAVB) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2018 |
AY2 2019 |
AY3 2020 |
AY4 2021 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .3 | .0 | .9 | .5 | .1 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -91.75 | 3337.57 | -41.91 | -87.65 | -30.33 | -30.33 | -30.33 | -30.33 | -30.33 |
| EBITDA | -10.8 | -10.8 | -10.6 | -11.5 | -13.9 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -3363.29 | -40641.69 | -1162.91 | -2164.89 | -21134.32 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .2 | .1 | .2 | .2 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 46.63 | 542.91 | 20.83 | 37.41 | 145.95 | 60.97 | 60.97 | 60.97 | 60.97 | 60.97 |
| EBIT | -11.0 | -11.0 | -10.8 | -11.7 | -14.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -3409.91 | -41184.6 | -1183.74 | -2202.3 | -21280.27 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 4.3 | 1.0 | 2.7 | 4.2 | 2.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .9 | 3.0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 6.56 | 3386.2 | 326.48 | 17.5 | 0.95961 | 45 | 45 | 45 | 45 | 45 |
| Inventories | .0 | -.9 | .2 | .2 | .4 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.00031005733 | -3386.2 | 18.56 | 28.44 | 650.92 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 |
| Accounts Payable | .4 | 1.1 | 1.2 | 1.4 | 2.1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 131.69 | 4177.88 | 126.96 | 267.41 | 3233.01 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.1 | -.4 | -.3 | -.4 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -14.32 | -213.01 | -45.23 | -61.98 | -594.57 | -64.31 | -64.31 | -64.31 | -64.31 | -64.31 |
| Tax Rate, % | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 | 0.000019766549 |
| EBITAT | -11.0 | -11.0 | -10.7 | -11.7 | -14.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -10.5 | -10.2 | -14.1 | -8.7 | -13.7 | -1.7 | .0 | .0 | .0 | .0 |
| WACC, % | 44.93 | 45.05 | 44.71 | 45.05 | 45.05 | 44.96 | 44.96 | 44.96 | 44.96 | 44.96 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 31 | |||||||||
| Equity Value Per Share | -0.05 |
What You Will Get
- Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Navidea Biopharmaceuticals, Inc.'s (NAVB) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template automatically computes Net Present Value (NPV) and intrinsic value for your convenience.
- Customizable and Professional: A sleek Excel model that can be tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing your time.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation frameworks tailored for Navidea Biopharmaceuticals, Inc. (NAVB).
- WACC Calculator: Includes a pre-designed Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Easily update growth projections, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Navidea Biopharmaceuticals, Inc. (NAVB).
- Interactive Dashboard and Charts: Visual representations to summarize essential valuation metrics for streamlined analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Navidea Biopharmaceuticals, Inc. (NAVB) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including Navidea's intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for Navidea Biopharmaceuticals, Inc. (NAVB)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Valuation: Observe immediate updates to Navidea's valuation as you modify the inputs.
- Preloaded Data: Comes with Navidea’s actual financial figures for swift evaluations.
- Preferred by Experts: Utilized by investors and analysts for making strategic decisions.
Who Should Use This Product?
- Healthcare Students: Explore biopharmaceutical valuation techniques and apply them using real-world data.
- Researchers: Integrate advanced models into your studies or clinical research.
- Investors: Evaluate your investment strategies and analyze valuation outcomes for Navidea Biopharmaceuticals, Inc. (NAVB).
- Market Analysts: Enhance your analysis with a customizable, pre-built valuation model tailored for biopharmaceuticals.
- Entrepreneurs: Understand how public biopharmaceutical companies like Navidea are assessed in the market.
What the Template Contains
- Historical Data: Includes Navidea Biopharmaceuticals, Inc.'s (NAVB) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Navidea Biopharmaceuticals, Inc.'s (NAVB) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital relevant to Navidea Biopharmaceuticals, Inc. (NAVB).
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions for Navidea Biopharmaceuticals, Inc. (NAVB).
- Quarterly and Annual Statements: A complete breakdown of Navidea Biopharmaceuticals, Inc.'s (NAVB) financials.
- Interactive Dashboard: Visualize valuation results and projections for Navidea Biopharmaceuticals, Inc. (NAVB) dynamically.